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The possible involvement of phospholipase A, (PLAJ in the release of catecholamines was examined in 
a cell-free model system, using isolated chromaffin granules and plasma membranes of adrenal medulla cells. 
Plasma membranes treated with PLA, in the presence of Ca2+ caused lysis of chromaffin granules which 
was also dependent on Ca *+ This finding suggests that Ca*+ . acts in two steps of exocytosis, namely in the 
transformation of plasma membranes into a lytic form by PLA, and in the interaction of chromaffin 
granules with plasma membranes. These findings show good agreement with recently reported findings in 
leaky adrenal medulla cells, and suggest he involvement of PLA, in the release of catecholamines. 
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1. INTRODUCTION 
Ca2+ plays a pivotal role in the exocytotic secre- 
tion of catecholamines from the adrenal medulla. 
Stimulation of the acetylcholine receptor evokes a 
rapid influx of Ca2+ [1,2] and a transient rise in 
cellular Ca’+, concentration [3] which triggers the 
secretory process. In leaky adrenal medulla cells 
[4-61 which were rendered permeable to Ca2+, 
micromolar Ca2+ was shown to cause exocytotic 
secretion of catecholamines. Phospholipase A2 
(PLA2, EC 3.1.1.4) is a Ca2+-dependent enzyme 
which releases unsaturated fatty acid from the 
sn-Zposition of membrane phospholipids. Be- 
cause lysophospholipids [7] and unsaturated fatty 
acids such as arachidonic acid [8] are known to be 
fusogens, it is possible that this enzyme plays a role 
in exocytosis. Recently, in leaky adrenal medulla 
cells, Frye and Holz [9] reported that Ca2+ caused 
the release of arachidonic acid in parallel with 
catecholamine release and suggested the possible 
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involvement of PLA2 in secretion of catechol- 
amines. We reported previously that cytoplasmic 
protein which was partially associated to micro- 
somes caused an all-or-none type lysis of chromaf- 
fin granules [lo] and that lysis of chromaffin 
granules was augmented by PLA2 in a Ca2+-depen- 
dent manner [ll]. Here, in an attempt to develop 
a cell-free experimental system for the study of the 
action of Ca2+ in exocytosis, we treated plasma 
membranes from bovine adrenal medulla with exo- 
genous PLA2 and investigated their interaction 
with chromaffin granules under controlled free 
Ca2+ concentrations in the medium. 
2. EXPERIMENTAL 
Fresh bovine adrenal medulla was used as the 
starting material. Chromaffin granules were iso- 
lated as in [ 121. Plasma membranes were isolated 
according to Meyer and Burger [ 131. Plasma mem- 
branes (5 mg protein/ml medium) were treated 
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with PLA2 (porcine pancreas, Boehringer, 3 U/ml) 
for 5 min at 37OC in a medium consisting of 
150mM KCl, 50mM Tris (pH 7.4) and 5 mM 
EGTA or Ca-EGTA (pCa 7.37-5.77). After incu- 
bation, plasma membranes were sedimented by 
centrifugation (105 000 x g, 1 h) and washed once 
with distilled water. Release of catecholamines was 
examined as follows. Chromaffin granules were in- 
cubated with PLAz-treated plasma membranes 
(50,ug/ml) in 150 mM KCI, 50mM Tris (pH 7.4), 
5 mM Ca-EGTA (pCa 7.37-5.77) for 5 min at 
37°C. After incubation, non-lysed granules and 
lysed granule membrane components were sedi- 
mented by centrifugation (20000 x g, 10 min). The 
supernatant was subjected to assay of catechol- 
amines [ 141 and dopamine &hydroxylase [ 151. 
3. RESULTS AND DISCUSSION 
Konings and De Potter [ 16-181 reported that 
plasma membranes from adrenal medulla cells 
caused, by themselves, a Ca2+-dependent release 
of catecholamines from the granules. However, 
Burgoyne [19] has indicated that they were unable 
to confirm this finding. In our experiment, plasma 
membranes which were not treated with PLA2 and 
those treated with PLAz in the presence of EGTA 
did not cause the release of catecholamines from 
chromaffin granules. In contrast, plasma mem- 
branes treated with PLA2 in the presence of free 
Ca2+ (pCa > 6.79) caused the release of catechol- 
amines (fig.lA). The half-maximal concentration 
of Ca2+ which was required in PLA2 treatment was 
pCa 6.7. The interaction of chromaffin granules 
with PLAz-treated plasma membranes was also 
dependent on free Ca’+, the half-maximal concen- 
tration being pCa 6.4 (fig. 1B). These findings sug- 
gest the possibility that Ca2+ has at least two ac- 
tions in the release of catecholamines, the activa- 
tion of PLA2 and the interaction of chromaffin 
granules with plasma membranes. Recently, in 
leaky adrenal medulla cells, micromolar Ca2+ has 
been shown to cause the release of arachidonic acid 
and catecholamines 191. In these cells, the concen- 
tration of Ca2+ which was required for release of 
arachidonic acid was lower than that for 
catecholamine release, showing a good agreement 
with our findings in the cell-free system. 
Release of catecholamines caused by PLAY 
treated plasma membranes was inhibited by high 
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Fig. 1. Release of catecholamines from chromaffin 
granules induced by PLAz-treated plasma membranes. 
(A) Plasma membranes were treated with PLA2 at 
various free Ca2+ concentrations. Incubation with chro- 
maffin granules was carried out for 5 min at 37°C. The 
free Ca*+ concentration during catecholamine reiease 
was adjusted to pCa 5.77. (B) Plasma membranes were 
treated with PLA2 in the presence of fixed Ca2+ (pCa 
5.77). Release of catecholamines was examined at 
various concentrations of free Ca2+ in the medium. 
Catecholamine release was expressed by percent release. 
Values are the means from 5 experiments each; SD 
shown by the vertical bars. 
concentration of Mg2+ (fig.2A). However, plasma 
membranes treated with PLAa in the absence or 
presence of Mg2+ showed the same lytic potency 
suggesting that Mg2+ did not inhibit the action of 
PLA2 (fig.ZB). This result again agrees with the 
finding in leaky cells that Mg’+ inhibited the re- 
lease of catecholamines but not of arachidonic acid 
[9]. Therefore, Mg”’ seems to antagonize preferen- 
tially the interaction of chromaffin granules with 
plasma membranes. 
Dopamine fl-hydroxylase, a large molecular 
marker of the soluble component of the granules, 
was released into the medium along with catechol- 
amines upon incubation with PLAz-treated plasma 
membranes (fig.3). This shows that release of 
catecholamines caused by PLAz-treated plasma 
membranes was due to the Iysis of chromaffin 
granules. In exocytotic secretion of catechol- 
amines, the soluble content of the granules is en- 
tirely extruded directly into the extracellular space. 
The all-or-none type lysis of granules observed in 
this experiment may represent the change in granule 
structure characteristic of exocytosis. In intact 
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Fig.2. Effect of Mg*+ on the release of catecholamines 
induced by PLAZ-treated plasma membranes. (A) 
Plasma membranes were treated with PLAz at various 
concentrations of MgCl2. Plasma membranes were 
collected by centrifugation and incubated with chromaf- 
fin granules in the absence of Mg*+. The free Ca*+ con- 
centration of the medium was pCu 5.77 throughout the 
experiment. (B) Chromaffin granules were incubated 
with PLAz-treated plasma membranes at various con- 
centrations of MgClz in the medium. The free Ca*+ con- 
centration in the medium was pCa 5.77. Values are the 
means from 4 experiments each; SD shown by the 
vertical bars. 
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Fig.3. Release of catecholamines and dopamine ,&hyd- 
roxylase from chromaffin granules induced by PLA2- 
treated plasma membranes. Chromaffin granules were 
incubated with various amounts of PLAZ-treated plasma 
membranes (S-5Opg protein/ml incubation medium). 
Catecholamines and dopamine ,&hydroxylase were 
assayed and expressed by percent release. Release of 
dopamine fl-hydroxylase was plotted vs release of 
catecholamines. 
adrenal medulla cells, influx of Ca*+ evoked by 
stimulation of acetylcholine receptor may activate 
endogenous PLAz of the cells and convert the 
plasma membranes into the lytic form, and Ca2+ 
also plays an indispensable role in the interaction 
of granules with plasma membranes. 
Recently accumulated evidence shows that PLA2 
activation is involved in several types of secretory 
processes (201. Moskowitz et al. [21] suggested that 
synaptic vesicle PLA2 activation may be an impor- 
tant mechanism underlying Ca*+-mediated neuro- 
transmitter release. In rat brain synaptosomes, 
Bradford et al. [22] suggested that Ca*+ influx by 
synaptosomal depolarization activated endogenous 
PLAz and modulated the secretion of catechol- 
amines. Activation of PLA2 by Ca*+ might be con- 
sidered as a preliminary step in triggering of the 
release process. In addition, our results suggest 
that Ca2+ also plays an indispensable role in the 
fusion of chromaffin granules with plasma mem- 
branes. 
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